Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 149

1.

Engineering Quantum States of Matter for Atomic Clocks in Shallow Optical Lattices.

Hutson RB, Goban A, Marti GE, Sonderhouse L, Sanner C, Ye J.

Phys Rev Lett. 2019 Sep 20;123(12):123401. doi: 10.1103/PhysRevLett.123.123401.

PMID:
31633951
2.

Emergence of multi-body interactions in a fermionic lattice clock.

Goban A, Hutson RB, Marti GE, Campbell SL, Perlin MA, Julienne PS, D'Incao JP, Rey AM, Ye J.

Nature. 2018 Nov;563(7731):369-373. doi: 10.1038/s41586-018-0661-6. Epub 2018 Oct 31.

PMID:
30429544
3.

Imaging Optical Frequencies with 100  μHz Precision and 1.1  μm Resolution.

Marti GE, Hutson RB, Goban A, Campbell SL, Poli N, Ye J.

Phys Rev Lett. 2018 Mar 9;120(10):103201. doi: 10.1103/PhysRevLett.120.103201.

PMID:
29570334
4.

Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase 2 study.

Ahn IE, Farooqui MZH, Tian X, Valdez J, Sun C, Soto S, Lotter J, Housel S, Stetler-Stevenson M, Yuan CM, Maric I, Calvo KR, Nierman P, Hughes TE, Saba NS, Marti GE, Pittaluga S, Herman SEM, Niemann CU, Pedersen LB, Geisler CH, Childs R, Aue G, Wiestner A.

Blood. 2018 May 24;131(21):2357-2366. doi: 10.1182/blood-2017-12-820910. Epub 2018 Feb 26.

5.

A Fermi-degenerate three-dimensional optical lattice clock.

Campbell SL, Hutson RB, Marti GE, Goban A, Darkwah Oppong N, McNally RL, Sonderhouse L, Robinson JM, Zhang W, Bloom BJ, Ye J.

Science. 2017 Oct 6;358(6359):90-94. doi: 10.1126/science.aam5538.

PMID:
28983047
6.

Direct in vivo evidence for increased proliferation of CLL cells in lymph nodes compared to bone marrow and peripheral blood.

Herndon TM, Chen SS, Saba NS, Valdez J, Emson C, Gatmaitan M, Tian X, Hughes TE, Sun C, Arthur DC, Stetler-Stevenson M, Yuan CM, Niemann CU, Marti GE, Aue G, Soto S, Farooqui MZH, Herman SEM, Chiorazzi N, Wiestner A.

Leukemia. 2017 Jun;31(6):1340-1347. doi: 10.1038/leu.2017.11. Epub 2017 Jan 11.

7.

Spin-orbit-coupled fermions in an optical lattice clock.

Kolkowitz S, Bromley SL, Bothwell T, Wall ML, Marti GE, Koller AP, Zhang X, Rey AM, Ye J.

Nature. 2017 Feb 2;542(7639):66-70. doi: 10.1038/nature20811. Epub 2016 Dec 21.

PMID:
28002409
8.

Verifying quantum superpositions at metre scales.

Stamper-Kurn DM, Marti GE, Müller H.

Nature. 2016 Sep 1;537(7618):E1-2. doi: 10.1038/nature19108. No abstract available.

PMID:
27582225
9.

Persistent immune alterations and comorbidities in splenectomized patients with Gaucher disease.

Sønder SU, Limgala RP, Ivanova MM, Ioanou C, Plassmeyer M, Marti GE, Alpan O, Goker-Alpan O.

Blood Cells Mol Dis. 2016 Jul;59:8-15. doi: 10.1016/j.bcmd.2016.02.003. Epub 2016 Feb 15.

PMID:
27282561
10.

Introduction to multiple myeloma special issue: The flow cytometric detection of minimal residual disease.

Preffer FI, Yuan CM, Lin P, Stetler-Stevenson M, Marti GE.

Cytometry B Clin Cytom. 2016 Jan;90(1):9-10. doi: 10.1002/cyto.b.21342. No abstract available.

11.

Disruption of in vivo Chronic Lymphocytic Leukemia Tumor-Microenvironment Interactions by Ibrutinib--Findings from an Investigator-Initiated Phase II Study.

Niemann CU, Herman SE, Maric I, Gomez-Rodriguez J, Biancotto A, Chang BY, Martyr S, Stetler-Stevenson M, Yuan CM, Calvo KR, Braylan RC, Valdez J, Lee YS, Wong DH, Jones J, Sun C, Marti GE, Farooqui MZ, Wiestner A.

Clin Cancer Res. 2016 Apr 1;22(7):1572-82. doi: 10.1158/1078-0432.CCR-15-1965. Epub 2015 Dec 9.

12.

Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib.

Sun C, Tian X, Lee YS, Gunti S, Lipsky A, Herman SE, Salem D, Stetler-Stevenson M, Yuan C, Kardava L, Moir S, Maric I, Valdez J, Soto S, Marti GE, Farooqui MZ, Notkins AL, Wiestner A, Aue G.

Blood. 2015 Nov 5;126(19):2213-9. doi: 10.1182/blood-2015-04-639203. Epub 2015 Sep 3. Erratum in: Blood. 2016 Aug 18;128(7):1020.

13.

Interactions between Ibrutinib and Anti-CD20 Antibodies: Competing Effects on the Outcome of Combination Therapy.

Skarzynski M, Niemann CU, Lee YS, Martyr S, Maric I, Salem D, Stetler-Stevenson M, Marti GE, Calvo KR, Yuan C, Valdez J, Soto S, Farooqui MZ, Herman SE, Wiestner A.

Clin Cancer Res. 2016 Jan 1;22(1):86-95. doi: 10.1158/1078-0432.CCR-15-1304. Epub 2015 Aug 17.

14.

Regulatory perspective on minimal residual disease flow cytometry testing in multiple myeloma.

Gormley NJ, Turley DM, Dickey JS, Farrell AT, Reaman GH, Stafford E, Carrington L, Marti GE.

Cytometry B Clin Cytom. 2016 Jan;90(1):73-80. doi: 10.1002/cyto.b.21268. Epub 2015 Jul 25.

15.

Systematic evaluation of an atomic clock at 2 × 10(-18) total uncertainty.

Nicholson TL, Campbell SL, Hutson RB, Marti GE, Bloom BJ, McNally RL, Zhang W, Barrett MD, Safronova MS, Strouse GF, Tew WL, Ye J.

Nat Commun. 2015 Apr 21;6:6896. doi: 10.1038/ncomms7896.

16.

Quantification of cells with specific phenotypes II: determination of CD4 expression level on reconstituted lyophilized human PBMC labelled with anti-CD4 FITC antibody.

Wang L, Stebbings R, Gaigalas AK, Sutherland J, Kammel M, John M, Roemer B, Kuhne M, Schneider RJ, Braun M, Engel A, Dikshit D, Abbasi F, Marti GE, Sassi M, Revel L, Kim SK, Baradez M, Lekishvili T, Marshall D, Whitby L, Jing W, Ost V, Vonsky M, Neukammer J.

Cytometry A. 2015 Mar;87(3):254-61. doi: 10.1002/cyto.a.22634. Epub 2015 Feb 5.

17.

Quantification of cells with specific phenotypes I: determination of CD4+ cell count per microliter in reconstituted lyophilized human PBMC prelabeled with anti-CD4 FITC antibody.

Stebbings R, Wang L, Sutherland J, Kammel M, Gaigalas AK, John M, Roemer B, Kuhne M, Schneider RJ, Braun M, Engel A, Dikshit DK, Abbasi F, Marti GE, Sassi MP, Revel L, Kim SK, Baradez MO, Lekishvili T, Marshall D, Whitby L, Jing W, Ost V, Vonsky M, Neukammer J.

Cytometry A. 2015 Mar;87(3):244-53. doi: 10.1002/cyto.a.22614. Epub 2015 Feb 5.

18.

Coherent magnon optics in a ferromagnetic spinor Bose-Einstein condensate.

Marti GE, MacRae A, Olf R, Lourette S, Fang F, Stamper-Kurn DM.

Phys Rev Lett. 2014 Oct 10;113(15):155302. Epub 2014 Oct 7.

PMID:
25375719
19.

Flow cytometry detection of minimal residual disease in multiple myeloma: Lessons learned at FDA-NCI roundtable symposium.

Landgren O, Gormley N, Turley D, Owen RG, Rawstron A, Paiva B, Barnett D, Arroz M, Wallace P, Durie B, Yuan C, Dogan A, Stetler-Stevenson M, Marti GE.

Am J Hematol. 2014 Dec;89(12):1159-60. doi: 10.1002/ajh.23831. No abstract available.

20.

Ibrutinib-induced lymphocytosis in patients with chronic lymphocytic leukemia: correlative analyses from a phase II study.

Herman SE, Niemann CU, Farooqui M, Jones J, Mustafa RZ, Lipsky A, Saba N, Martyr S, Soto S, Valdez J, Gyamfi JA, Maric I, Calvo KR, Pedersen LB, Geisler CH, Liu D, Marti GE, Aue G, Wiestner A.

Leukemia. 2014 Nov;28(11):2188-96. doi: 10.1038/leu.2014.122. Epub 2014 Apr 4.

21.

Monoclonal B-cell lymphocytosis in healthy blood donors: an unexpectedly common finding.

Shim YK, Rachel JM, Ghia P, Boren J, Abbasi F, Dagklis A, Venable G, Kang J, Degheidy H, Plapp FV, Vogt RF, Menitove JE, Marti GE.

Blood. 2014 Feb 27;123(9):1319-26. doi: 10.1182/blood-2013-08-523704. Epub 2013 Dec 17.

22.

Concerning the article by de Carvalho Bittencourt et al.: Value of HIV patients with regular follow-up as in-house internal controls of flow cytometry measurement of lymphocyte subsets.

Marti GE, Mandy F, Denny T, Preffer FI.

Cytometry B Clin Cytom. 2013 Sep-Oct;84(5):327-8. doi: 10.1002/cyto.b.21113. No abstract available.

23.

ICSH/ICCS practice guidelines special issue.

Béné MC, Marti GE.

Cytometry B Clin Cytom. 2013 Sep-Oct;84(5):279-80. doi: 10.1002/cyto.b.21121. No abstract available.

24.

Bcl-2 level as a biomarker for 13q14 deletion in CLL.

Degheidy HA, Gadalla SM, Farooqui MZ, Abbasi F, Arthur DC, Bauer SR, Wilson WH, Wiestner A, Stetler-Stevenson MA, Marti GE.

Cytometry B Clin Cytom. 2013 Jul-Aug;84(4):237-47. doi: 10.1002/cyto.b.21090. Epub 2013 May 14.

25.

Quantitative detection of zeta-chain-associated protein 70 expression in chronic lymphocytic leukemia.

Zhu P, Degheidy HA, Marti GE, Li S, Abbasi F, Wiestner A, Amstutz P, Tang CM.

Leuk Lymphoma. 2013 Mar;54(3):579-86. doi: 10.3109/10428194.2012.715349. Epub 2012 Aug 14.

26.

Human CD4+ lymphocytes for antigen quantification: characterization using conventional flow cytometry and mass cytometry.

Wang L, Abbasi F, Ornatsky O, Cole KD, Misakian M, Gaigalas AK, He HJ, Marti GE, Tanner S, Stebbings R.

Cytometry A. 2012 Jul;81(7):567-75. doi: 10.1002/cyto.a.22060. Epub 2012 Apr 26.

27.

MBL: mostly benign lymphocytes, but...

Marti GE.

Blood. 2011 Dec 15;118(25):6480-1. doi: 10.1182/blood-2011-09-379073.

PMID:
22174306
28.

Combined normal donor and CLL: Single tube ZAP-70 analysis.

Degheidy HA, Venzon DJ, Farooqui MZ, Abbasi F, Arthur DC, Wilson WH, Wiestner A, Stetler-Stevenson MA, Marti GE.

Cytometry B Clin Cytom. 2012 Mar;82(2):67-77. doi: 10.1002/cyto.b.20622. Epub 2011 Oct 26.

29.

The detection of minimal residual disease status in chronic lymphocytic leukemia.

Marti GE.

Cytometry B Clin Cytom. 2011 Nov;80(6):344-5. doi: 10.1002/cyto.b.20625. No abstract available.

30.

Phase I trial of 7-hydroxystaurosporine and fludararbine phosphate: in vivo evidence of 7-hydroxystaurosporine induced apoptosis in chronic lymphocytic leukemia.

Marti GE, Stetler-Stevenson M, Grant ND, White T, Figg WD, Tohnya T, Jaffe ES, Dunleavy K, Janik JE, Steinberg SM, Wilson WH.

Leuk Lymphoma. 2011 Dec;52(12):2284-92. doi: 10.3109/10428194.2011.589547. Epub 2011 Jul 12.

31.

Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL.

Lanasa MC, Allgood SD, Slager SL, Dave SS, Love C, Marti GE, Kay NE, Hanson CA, Rabe KG, Achenbach SJ, Goldin LR, Camp NJ, Goodman BK, Vachon CM, Spector LG, Rassenti LZ, Leis JF, Gockerman JP, Strom SS, Call TG, Glenn M, Cerhan JR, Levesque MC, Weinberg JB, Caporaso NE.

Leukemia. 2011 Sep;25(9):1459-66. doi: 10.1038/leu.2011.117. Epub 2011 May 27.

32.

Improved ZAP-70 assay using two clones, multiple methods of analysis and clinical correlation.

Degheidy HA, Venzon DJ, Farooqui MZ, Abbasi F, Arthur DC, Wilson WH, Wiestner A, Stetler-Stevenson MA, Marti GE.

Cytometry B Clin Cytom. 2011 Sep;80(5):309-17. doi: 10.1002/cyto.b.20593. Epub 2011 Apr 6.

33.

Methodological comparison of two anti-ZAP-70 antibodies.

Degheidy HA, Venzon DJ, Farooqui MZ, Abbasi F, Arthur DC, Wilson WH, Wiestner A, Stetler-Stevenson MA, Marti GE.

Cytometry B Clin Cytom. 2011 Sep;80(5):300-8. doi: 10.1002/cyto.b.20591. Epub 2011 Apr 6.

34.

Familial Aspects of Chronic Lymphocytic Leukemia, Monoclonal B-Cell Lymphocytosis (MBL), and Related Lymphomas.

Goldin LR, Landgren O, Marti GE, Caporaso NE.

European J Clin Med Oncol. 2010 Feb;2(1):119-126.

35.

Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL.

Slager SL, Rabe KG, Achenbach SJ, Vachon CM, Goldin LR, Strom SS, Lanasa MC, Spector LG, Rassenti LZ, Leis JF, Camp NJ, Glenn M, Kay NE, Cunningham JM, Hanson CA, Marti GE, Weinberg JB, Morrison VA, Link BK, Call TG, Caporaso NE, Cerhan JR.

Blood. 2011 Feb 10;117(6):1911-6. doi: 10.1182/blood-2010-09-308205. Epub 2010 Dec 3.

36.

The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia.

Herishanu Y, Pérez-Galán P, Liu D, Biancotto A, Pittaluga S, Vire B, Gibellini F, Njuguna N, Lee E, Stennett L, Raghavachari N, Liu P, McCoy JP, Raffeld M, Stetler-Stevenson M, Yuan C, Sherry R, Arthur DC, Maric I, White T, Marti GE, Munson P, Wilson WH, Wiestner A.

Blood. 2011 Jan 13;117(2):563-74. doi: 10.1182/blood-2010-05-284984. Epub 2010 Oct 12.

37.

Variables affecting the quantitation of CD22 in neoplastic B cells.

Jasper GA, Arun I, Venzon D, Kreitman RJ, Wayne AS, Yuan CM, Marti GE, Stetler-Stevenson M.

Cytometry B Clin Cytom. 2011 Mar;80(2):83-90. doi: 10.1002/cyto.b.20567. Epub 2010 Sep 24.

38.

Enhanced and reduced atom number fluctuations in a BEC splitter.

Maussang K, Marti GE, Schneider T, Treutlein P, Li Y, Sinatra A, Long R, Estève J, Reichel J.

Phys Rev Lett. 2010 Aug 20;105(8):080403. Epub 2010 Aug 19.

PMID:
20868082
39.

Long-term follow-up of monoclonal B-cell lymphocytosis detected in environmental health studies.

Marti GE, Shim YK, Albitar M, Middleton D, Abbasi F, Anderson A, Vogt RF.

Cytometry B Clin Cytom. 2010;78 Suppl 1:S83-90. doi: 10.1002/cyto.b.20522.

40.

Human peripheral blood B-cell compartments: a crossroad in B-cell traffic.

Perez-Andres M, Paiva B, Nieto WG, Caraux A, Schmitz A, Almeida J, Vogt RF Jr, Marti GE, Rawstron AC, Van Zelm MC, Van Dongen JJ, Johnsen HE, Klein B, Orfao A; Primary Health Care Group of Salamanca for the Study of MBL.

Cytometry B Clin Cytom. 2010;78 Suppl 1:S47-60. doi: 10.1002/cyto.b.20547. Review.

41.

Commentary: Comparison of current flow cytometry methods for monoclonal B cell lymphocytosis detection.

Nieto WG, Almeida J, Teodosio C, Abbasi F, Allgood SD, Connors F, Rachel JM, Ghia P, Lanasa MC, Rawstron AC, Orfao A, Caporaso NE, Hanson CA, Shim YK, Vogt RF, Marti GE.

Cytometry B Clin Cytom. 2010;78 Suppl 1:S4-9. doi: 10.1002/cyto.b.20556.

42.

Monoclonal B cell lymphocytosis: clinical and population perspectives.

Caporaso NE, Marti GE, Landgren O, Azzato E, Weinberg JB, Goldin L, Shanafelt T.

Cytometry B Clin Cytom. 2010;78 Suppl 1:S115-9. doi: 10.1002/cyto.b.20555. Review.

43.

Prevalence of monoclonal B-cell lymphocytosis: a systematic review.

Shim YK, Middleton DC, Caporaso NE, Rachel JM, Landgren O, Abbasi F, Raveche ES, Rawstron AC, Orfao A, Marti GE, Vogt RF.

Cytometry B Clin Cytom. 2010;78 Suppl 1:S10-8. doi: 10.1002/cyto.b.20538. Review.

44.

Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL families.

Goldin LR, Lanasa MC, Slager SL, Cerhan JR, Vachon CM, Strom SS, Camp NJ, Spector LG, Leis JF, Morrison VA, Glenn M, Rabe KG, Achenbach SJ, Algood SD, Abbasi F, Fontaine L, Yau M, Rassenti LZ, Kay NE, Call TG, Hanson CA, Weinberg JB, Marti GE, Caporaso NE.

Br J Haematol. 2010 Oct;151(2):152-8. doi: 10.1111/j.1365-2141.2010.08339.x. Epub 2010 Aug 25.

45.

Variables in the quantification of CD4 in normals and hairy cell leukemia patients.

Wang L, Abbasi F, Jasper GA, Kreitman RJ, Liewehr DJ, Marti GE, Stetler-Stevenson M.

Cytometry B Clin Cytom. 2011 Jan;80(1):51-6. doi: 10.1002/cyto.b.20541.

46.

Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32.

Conde L, Halperin E, Akers NK, Brown KM, Smedby KE, Rothman N, Nieters A, Slager SL, Brooks-Wilson A, Agana L, Riby J, Liu J, Adami HO, Darabi H, Hjalgrim H, Low HQ, Humphreys K, Melbye M, Chang ET, Glimelius B, Cozen W, Davis S, Hartge P, Morton LM, Schenk M, Wang SS, Armstrong B, Kricker A, Milliken S, Purdue MP, Vajdic CM, Boyle P, Lan Q, Zahm SH, Zhang Y, Zheng T, Becker N, Benavente Y, Boffetta P, Brennan P, Butterbach K, Cocco P, Foretova L, Maynadié M, de Sanjosé S, Staines A, Spinelli JJ, Achenbach SJ, Call TG, Camp NJ, Glenn M, Caporaso NE, Cerhan JR, Cunningham JM, Goldin LR, Hanson CA, Kay NE, Lanasa MC, Leis JF, Marti GE, Rabe KG, Rassenti LZ, Spector LG, Strom SS, Vachon CM, Weinberg JB, Holly EA, Chanock S, Smith MT, Bracci PM, Skibola CF.

Nat Genet. 2010 Aug;42(8):661-4. doi: 10.1038/ng.626. Epub 2010 Jul 18.

47.

Genetic susceptibility variants for chronic lymphocytic leukemia.

Slager SL, Goldin LR, Strom SS, Lanasa MC, Spector LG, Rassenti L, Leis JF, Camp NJ, Kay NE, Vachon CM, Glenn M, Weinberg JB, Rabe KG, Cunningham JM, Achenbach SJ, Hanson CA, Marti GE, Call TG, Caporaso NE, Cerhan JR.

Cancer Epidemiol Biomarkers Prev. 2010 Apr;19(4):1098-102. doi: 10.1158/1055-9965.EPI-09-1217. Epub 2010 Mar 23.

48.

Evolution of a precursor.

Caporaso NE, Marti GE, Vogt RF Jr, Shim YK, Middleton D, Landgren O; International MBL Study Group.

Cytometry B Clin Cytom. 2010 Jan;78(1):1-3. doi: 10.1002/cyto.b.20508. No abstract available.

49.

Evidence of serum immunoglobulin abnormalities up to 9.8 years before diagnosis of chronic lymphocytic leukemia: a prospective study.

Tsai HT, Caporaso NE, Kyle RA, Katzmann JA, Dispenzieri A, Hayes RB, Marti GE, Albitar M, Ghia P, Rajkumar SV, Landgren O.

Blood. 2009 Dec 3;114(24):4928-32. doi: 10.1182/blood-2009-08-237651. Epub 2009 Oct 14.

50.

The changing definition of CLL.

Marti GE.

Blood. 2009 Apr 30;113(18):4130-1. doi: 10.1182/blood-2008-12-193656. No abstract available.

PMID:
19406995

Supplemental Content

Loading ...
Support Center